Nonhormonal treatment guides
Understand the approach.
Keep the details.
Read about treatment families, newer medicines, product-specific safety and the goals to bring to a menopause discussion.
Guide
Nonhormonal hot-flash treatments: different families, different questions
Separate antidepressant medicines, neurokinin-targeted treatments, other prescriptions and evidence-based non-drug support without ranking them for an individual.
Guide
Fezolinetant and liver monitoring: understand the responsibility behind the tests
What Veozah's current boxed warning adds to a hot-flash treatment discussion, and why a laboratory order needs a clear review and response process.
Guide
Elinzanetant for menopause: what Lynkuet's evidence establishes now
Read the 2025 approval alongside the current August 2026 safety information, with the trial outcomes and remaining uncertainties kept in view.
Guide
Prepare a nonhormonal menopause visit around the result that matters to you
Bring symptom priorities, previous treatment experience and practical follow-up questions without trying to choose a prescription from an online checklist.